Join the Wegovy group to help and get support from people like you.
Wegovy News (Page 2)
Semaglutide Linked to Nonarteritic Anterior Ischemic Optic Neuropathy
WEDNESDAY, July 3, 2024 – Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity,...
GLP-1 Drugs Ozempic, Wegovy Linked to Rare Blinding Condition
WEDNESDAY, July 3, 2024 – Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns. People with diabetes prescribed semaglutide...
Another Study Suggests GLP-1 Meds Could Ease Alcoholism
TUESDAY, July 2, 2024 – Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide had 50% to 56% decreased odds for either...
Another Study Suggests GLP-1 Meds Could Ease Alcoholism
TUESDAY, July 2, 2024 – Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide had 50% to 56% decreased odds for either...
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians,...
ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure
WEDNESDAY, June 26, 2024 – For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women but yields similar...
Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms
TUESDAY, June 24, 2024 – Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows. Both men and women showed improved heart function after a year on...
Semaglutide Cuts Incidence, Recurrence of Alcohol Use Disorder
TUESDAY, June 25, 2024 – Semaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according to a study published online May 28 in Nature Communications. ...
WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs
FRIDAY, JUNE 21, 2024 – Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous...
GLP-1 Meds May Help Extremely Obese Qualify for Weight-Loss Surgery
FRIDAY, June 14, 2024 – Taking a cutting-edge weight-loss drug could help extremely obese patients drop enough pounds to be eligible for bariatric surgery, a new study shows. Patients with extreme...
GLP-1 RA Use Linked to Lower Quality of Bowel Preparation
THURSDAY, June 13, 2024 – The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing...
Patients Can Take GLP-1 RA Medications Before Surgery
WEDNESDAY, June 12, 2024 – Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications do slow gastric emptying but not by enough to warrant discontinuing medications before surgery, according...
Taking a GLP-1 Medicine? Here's What Experts Say You Should Eat
TUESDAY, June 11, 2024 – Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements for good health, even if they’re eating less. A new set of nutritional r...
Greater Reduction Seen in Mortality With Bariatric Surgery Than GLP-1 RAs
MONDAY, June 10, 2024 – Bariatric metabolic surgery (BMS) is associated with a greater reduction in mortality than glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment among adults with a...
It's Safe to Take GLP-1 Weight Loss Meds Before Surgery: Study
THURSDAY, June 6, 2024 – Despite recent concerns that taking Ozempic, Wegovy or other GLP-1 medications might be unsafe before a surgery, a new review has uncovered no such danger. The issue arose...
Further information
Related condition support groups
Weight Loss (Obesity / Overweight), Cardiovascular Risk Reduction